New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Anebulo Pharmaceuticals, Inc.
ANEB
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

49M

Biotechnology

Next Earning date - 12 Nov 2024

49M

Biotechnology

Next Earning date - 12 Nov 2024

1.88USD
Shape-0.01Ā ( -0.53%)
favorite-chart

Relative Strenght

18
favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

43%

Quote Panel

Shape
Updated October 14, 2024
1W -0.53 % 1M -10.05 % 3M -22.31 % 1Y 9.94 %

Key Metrics

Shape
  • Market Cap

    48.75M


  • Shares Outstanding

    25.93M


  • Share in Float

    9.28M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.88


  • Average Volume

    7343


  • Beta

    -1.016


  • Range

    1.62-3.3


  • Industry

    Biotechnology


  • Website

    https://www.anebulo.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

12.73x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-0.3

EPS

How ANEB compares to sector?

P/E Ratio

Relative Strength

Shape

ANEB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$0.55

Shape-952%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2023-09-18

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.11
vsĀ -0.07

Q4.22

arrow
arrow

N/A

-0.15
vsĀ -0.05

Q1.23

arrow
arrow

N/A

-0.11
vsĀ -0.08

Q2.23

arrow
arrow

N/A

-0.10
vsĀ -0.10

Q3.23

arrow
arrow

N/A

-0.10
vsĀ -0.11

Q4.23

arrow
arrow

N/A

-0.11
vsĀ -0.15

Q1.24

arrow
arrow

N/A

-0.06
vsĀ -0.11

Q2.24

arrow
arrow

N/A

-0.05
vsĀ -0.10

Q3.24

arrow
arrow

N/A

-0.05
vsĀ -0.10

Q4.24

arrow
arrow

N/A

-0.05
vsĀ -0.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q2.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q3.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q4.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q1.23

arrow
arrow

NA

NAĀ  vsĀ NA

Q2.23

arrow
arrow

NA

NAĀ  vsĀ NA

Q3.23

arrow
arrow

NA

NAĀ  vsĀ NA

Q4.23

arrow
arrow

NA

NAĀ  vsĀ NA

Q1.24

arrow
arrow

NA

NAĀ  vsĀ NA

Q2.24

arrow
arrow

NA

NAĀ  vsĀ NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vsĀ -0.15

Q4.22

arrow
arrow

-25%

-0.25
vsĀ -0.14

Q1.23

arrow
arrow

-21%

-0.21
vsĀ -0.25

Q2.23

arrow
arrow

-24%

-0.24
vsĀ -0.21

Q3.23

arrow
arrow

-30%

-0.30
vsĀ -0.24

Q4.23

arrow
arrow

-42%

-0.42
vsĀ -0.30

Q1.24

arrow
arrow

-33%

-0.33
vsĀ -0.42

Q2.24

arrow
arrow

-35%

-0.35
vsĀ -0.33

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

10

10
vsĀ 8

25%

Q4.22

arrow
arrow

12

12
vsĀ 10

20%

Q1.23

arrow
arrow

9

9
vsĀ 12

-25%

Q2.23

arrow
arrow

11

11
vsĀ 9

22%

Q3.23

arrow
arrow

11

11
vsĀ 11

NA

Q4.23

arrow
arrow

13

13
vsĀ 11

18%

Q1.24

arrow
arrow

14

14
vsĀ 13

8%

Q2.24

arrow
arrow

12

12
vsĀ 14

-14%

Earnings Growth

Latest News